Тhe Farmak delegation took part in the last conference and meeting of the ORBIS project in the city of Poznan, Poland. The project lasted 5 years as part of the…
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…